CreaGene to initiate phase 2 study for liver cancer vaccine
Published: 2010-09-10 06:57:00
Updated: 2010-09-10 06:57:00
CreaGene Inc., an affiliated company of Choongwae Pharm, said on September 7 that it will conduct its local phase 2 clinical trials for CreaVax-HCC Inj. in five university hospitals, including Seoul National University Hospital and Samsung Medical Center.
For this study a total of 150 patients...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
